Using cord blood eye drops to heal corneal damage in lung cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of cord blood serum eye drops in promoting the healing of corneal epithelium in patients receiving EGFR inhibitor treatment for lung cancer. The intervention involves administering these eye drops over a one-month period to assess their impact on corneal damage caused by the medication. The study focuses on oncology patients with EGFR mutations who are experiencing severe keratopathy as a side effect of their treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* age over 18 years
* oncology and advanced cancer patients who have EGFr mutation and who require treatment with antiEGFr drugs
* signing of informed consent

Exclusion Criteria:

* Patients who are unable to store/administer the CSCO independently, or with the help of care-givers.

Where it's running

• IRCCS Azienda Ospedaliero-Universitaria di Bologna
  Bologna, Italy Recruiting

Study contacts

• Principal investigator: Luigi Fontana, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
• Study coordinator: Luigi Fontana, MD
• Email: luigi.fontana6@unibo.it
• Phone: +390512142837

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Lacrifill to Help Prevent Post-Curgery Dry Eye After Cataract Surgery

  This study tests Lacrifill to see if it helps prevent dry eye symptoms after unilateral cataract surgery.

  Recruiting at 2 sites Phase 4 Eye Research Associates, LLC · Pittsburg, Kansas and 1 other locations · NCT07796178

• Tear-Fluid Stability Testing with iTrace, BOSA, OPD-Scan III, and IDRA for Dry Eye

  A Phase 4 study tests whether four eye devices can detect tear film stability in adults with normal tear film.

  Recruiting Phase 4 Vance Thompson Vision · Sioux Falls, South Dakota · NCT07790211

• OT202 1% eye drops for moderate to severe dry eye

  This phase 3 study tests whether 1% OT202 eye drops help people with moderate to severe dry eye better than a placebo.

  Recruiting Phase 3 Ocumension Therapeutics (Suzhou) Co., Ltd · Bengbu, Anhui and 48 other locations · NCT07740564

• Tyrvaya Nasal Spray for Comfort in Contact Lens Wearers

  This study tests whether using Tyrvaya twice daily can improve comfort for adults who wear soft contact lenses and have dry eye symptoms.

  Recruiting Ocular Aesthetics, LLC dba Ocular Clinical Trials · Houston, Texas · NCT07705893

• Long-term effects of Acoltremon vs. control in dry eye disease

  This study tests whether Acoltremon eye drops help people with dry eye over a year compared with a preservative-free artificial tear, at a single center.

  Recruiting The Eye Care Institute · Louisville, Kentucky · NCT07659626

• Effect of Dry Eye Treatment on Corneal Astigmatism Measurements

  This study tests whether short-term treatment for dry eye changes how consistently three devices measure corneal astigmatism in people preparing for cataract surgery.

  Recruiting Eye & ENT Hospital of Fudan University · Shanghai, Shanghai Municipality · NCT07657858

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.